Influence of demethylation on regulatory T and Th17 cells in myelodysplastic syndrome

Myelodysplastic syndrome (MDS) represents a heterogeneous hematopoietic disorder in which mature blood cells are derived from an abnormal multipotent progenitor cell. The current therapy for MDS involves repeated cycles of DNA methyltransferase (DNMT) inhibitors, particularly the demethylation drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Xinyan, Yang, Wenzhong, Zhou, Xiaohui, Han, Lu, Shi, Jumei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924080/
https://www.ncbi.nlm.nih.gov/pubmed/31897157
http://dx.doi.org/10.3892/ol.2019.11114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924080/
https://www.ncbi.nlm.nih.gov/pubmed/31897157
http://dx.doi.org/10.3892/ol.2019.11114

Ejemplares similares